Nuclear Medicine - Global Market Outlook (2017-2026)

Nuclear Medicine - Global Market Outlook (2017-2026)

  • Published: October 2018
  • ID: SMRC17666

According to Stratistics MRC, the Global Nuclear Medicine is accounted for $3.50 billion in 2017 and is expected to reach $6.50 billion by 2026 growing at a CAGR of 7.1% during the forecast period. Factors such as growing demand for early & precise diagnostic methods, increasing incidence of cancer and cardiovascular disorders and huge demand for single photon emission computed tomography (SPECT) and positron emission tomography (PET) imaging are driving the market growth. However, supply deficiency, reimbursement hurdles for the manufacturer and high capital investment are restricting the growth of the growth. Moreover, rising economies, upcoming radioisotopes and increasing usage across neurological applications are providing ample opportunities for the market growth.

Nuclear medicines are used for both diagnostic and therapeutic uses and there are more than 30 specific radiopharmaceuticals used by medical practitioners. Nuclear medicine comes under the field of molecular imaging, which occupy the use of very little amount of radioactive material to detect and treat disease Several forms of nuclear medicines are required in treating cancer, neurological disorders, gastrointestinal and other diseases.

On the basis of application, therapeutic segment witnessed steady growth due to the introduction of advanced protective measures and growing awareness regarding the therapeutic procedures. By geography, North America is dominating the market during the forecasting period owing to increasing aging population, technological advancements and the presence of favorable reimbursement policies in this region.

Some of the key players in the Nuclear Medicine Market include Bayer AG, Medtronic, plc, General Electric Co., Cardinal Health, Inc., IBA Group, BWX Technologies, Australian Nuclear Science & Technology Organization (ANSTO), Mallinckrodt plc., Eckert & Ziegler Group, Lantheus Medical Imaging, Inc., Jubilant Life Sciences, Eczacibasi-Monrol Nuclear Products, Curium, Bracco Imaging S.p.A and NTP Radioisotopes SOC Ltd.

Products Covered:
• Therapeutic
• Diagnostic
 
Applications Covered:
• Therapeutic Applications
• Diagnostic Applications
 
End Users Covered:
• Research institutes 
• Hospitals and Diagnostic centers 
 
Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan       
    • China       
    • India       
    • Australia 
    • New Zealand     
    • South Korea      
    • Rest of Asia Pacific   
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 9 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

1 Executive Summary           
             
2 Preface             
 2.1 Abstract           
 2.2 Stake Holders          
 2.3 Research Scope          
 2.4 Research Methodology         
  2.4.1 Data Mining         
  2.4.2 Data Analysis         
  2.4.3 Data Validation         
  2.4.4 Research Approach          
 2.5 Research Sources          
  2.5.1 Primary Research Sources        
  2.5.2 Secondary Research Sources        
  2.5.3 Assumptions         
             
3 Market Trend Analysis          
 3.1 Introduction          
 3.2 Drivers           
 3.3 Restraints          
 3.4 Opportunities          
 3.5 Threats           
 3.6 Product Analysis          
 3.7 Application Analysis         
 3.8 End User Analysis          
 3.9 Emerging Markets          
 3.10 Futuristic Market Scenario          
             
4 Porters Five Force Analysis          
 4.1 Bargaining power of suppliers         
 4.2 Bargaining power of buyers         
 4.3 Threat of substitutes         
 4.4 Threat of new entrants         
 4.5 Competitive rivalry           
             
5 Global Nuclear Medicine Market, By Product        
 5.1 Introduction          
 5.2 Therapeutic          
  5.2.1 Brachytherapy         
   5.2.1.1 Iodine-125        
   5.2.1.2 Iridium-192        
   5.2.1.3 Cesium-131        
   5.2.1.4 Palladium-103        
   5.2.1.5 Other Brachytherapies       
  5.2.2 Beta emitters         
   5.2.2.1 Lu-117         
   5.2.2.2 Iodine-131        
   5.2.2.3 Samarium-153        
   5.2.2.4 Yttrium-90        
   5.2.2.5 Rhenium 186/188         
   5.2.2.6 Strontium 89        
   5.2.2.7 Other beta emitters        
  5.2.3 Alpha emitters         
   5.2.3.1 RA-223         
   5.2.3.2 Other alpha emitters       
 5.3 Diagnostic           
  5.3.1 Positron Emission Tomography (PET)        
   5.3.1.1 RB-82         
   5.3.1.2 F-18         
   5.3.1.3 Other PET products        
  5.3.2 Single Photon Emission Computed Tomography (SPECT)     
   5.3.2.1 TL-201         
   5.3.2.2 TC-99m         
   5.3.2.3 GA-67         
   5.3.2.4 Other SPECT products       
             
6 Global Nuclear Medicine Market, By Application        
 6.1 Introduction          
 6.2 Therapeutic           
  6.2.1 Endocrine Tumors         
  6.2.2 Lymphoma         
  6.2.3 Bone Metastasis         
  6.2.4 Thyroid          
  6.2.5 Other Therapeutic Applications       
 6.3 Diagnostic           
  6.3.1 Thyroid          
  6.3.2 Neurology         
  6.3.3 Lymphoma         
  6.3.4 Cardiology         
  6.3.5 Oncology          
  6.3.6 Other Diagnostics         
             
7 Global Nuclear Medicine Market, By End User        
 7.1 Introduction          
 7.2 Research institutes          
 7.3 Hospitals and diagnostic centers        
             
8 Global Nuclear Medicine Market, By Geography        
 8.1 Introduction          
 8.2 North America          
  8.2.1 US          
  8.2.2 Canada          
  8.2.3 Mexico          
 8.3 Europe           
  8.3.1 Germany          
  8.3.2 UK          
  8.3.3 Italy          
  8.3.4 France          
  8.3.5 Spain          
  8.3.6 Rest of Europe         
 8.4 Asia Pacific          
  8.4.1 Japan          
  8.4.2 China          
  8.4.3 India          
  8.4.4 Australia          
  8.4.5 New Zealand         
  8.4.6 South Korea         
  8.4.7 Rest of Asia Pacific         
 8.5 South America          
  8.5.1 Argentina         
  8.5.2 Brazil          
  8.5.3 Chile          
  8.5.4 Rest of South America        
 8.6 Middle East & Africa         
  8.6.1 Saudi Arabia         
  8.6.2 UAE          
  8.6.3 Qatar          
  8.6.4 South Africa         
  8.6.5 Rest of Middle East & Africa        
             
9 Key Developments           
 9.1 Agreements, Partnerships, Collaborations and Joint Ventures      
 9.2 Acquisitions & Mergers         
 9.3 New Product Launch         
 9.4 Expansions          
 9.5 Other Key Strategies         
             
10 Company Profiling           
 10.1 Bayer AG           
 10.2 Medtronic, plc          
 10.3 General Electric Co.          
 10.4 Cardinal Health, Inc.         
 10.5 IBA Group          
 10.6 BWX Technologies          
 10.7 Australian Nuclear Science & Technology Organization (ANSTO)     
 10.8 Mallinckrodt plc.          
 10.9 Eckert & Ziegler Group         
 10.10 Lantheus Medical Imaging, Inc.        
 10.11 Jubilant Life Sciences         
 10.12 Eczacibasi-Monrol Nuclear Products         
 10.13 Curium            
 10.14 Bracco Imaging S.p.A         
 10.15 NTP Radioisotopes SOC Ltd.          


List of Tables            
1 Global Nuclear Medicine Market Outlook, By Region (2016-2026) (US $MN)      
2 Global Nuclear Medicine Market Outlook, By Product (2016-2026) (US $MN)      
3 Global Nuclear Medicine Market Outlook, By Therapeutic (2016-2026) (US $MN)      
4 Global Nuclear Medicine Market Outlook, By Brachytherapy (2016-2026) (US $MN)      
5 Global Nuclear Medicine Market Outlook, By Beta emitters (2016-2026) (US $MN)      
6 Global Nuclear Medicine Market Outlook, By Alpha emitters (2016-2026) (US $MN)      
7 Global Nuclear Medicine Market Outlook, By Diagnostic (2016-2026) (US $MN)      
8 Global Nuclear Medicine Market Outlook, By PET (2016-2026) (US $MN)       
9 Global Nuclear Medicine Market Outlook, By SPECT (2016-2026) (US $MN)      
10 Global Nuclear Medicine Market Outlook, By Application (2016-2026) (US $MN)      
11 Global Nuclear Medicine Market Outlook, By Therapeutic (2016-2026) (US $MN)      
12 Global Nuclear Medicine Market Outlook, By Endocrine Tumors (2016-2026) (US $MN)     
13 Global Nuclear Medicine Market Outlook, By Lymphoma (2016-2026) (US $MN)      
14 Global Nuclear Medicine Market Outlook, By Bone Metastasis (2016-2026) (US $MN)     
15 Global Nuclear Medicine Market Outlook, By Thyroid (2016-2026) (US $MN)      
16 Global Nuclear Medicine Market Outlook, By Other Therapeutic Applications (2016-2026) (US $MN)    
17 Global Nuclear Medicine Market Outlook, By Diagnostic (2016-2026) (US $MN)      
18 Global Nuclear Medicine Market Outlook, By Thyroid (2016-2026) (US $MN)      
19 Global Nuclear Medicine Market Outlook, By Neurology (2016-2026) (US $MN)      
20 Global Nuclear Medicine Market Outlook, By Lymphoma (2016-2026) (US $MN)      
21 Global Nuclear Medicine Market Outlook, By Cardiology (2016-2026) (US $MN)      
22 Global Nuclear Medicine Market Outlook, By Oncology (2016-2026) (US $MN)      
23 Global Nuclear Medicine Market Outlook, By Other Diagnostics (2016-2026) (US $MN)     
24 Global Nuclear Medicine Market Outlook, By End User (2016-2026) (US $MN)      
25 Global Nuclear Medicine Market Outlook, By Research institutes (2016-2026) (US $MN)     
26 Global Nuclear Medicine Market Outlook, By Hospitals and diagnostic centers (2016-2026) (US $MN)    
27 North America Nuclear Medicine Market Outlook, By Country (2016-2026) (US $MN)     
28 North America Nuclear Medicine Market Outlook, By Product (2016-2026) (US $MN)     
29 North America Nuclear Medicine Market Outlook, By Therapeutic (2016-2026) (US $MN)     
30 North America Nuclear Medicine Market Outlook, By Brachytherapy (2016-2026) (US $MN)     
31 North America Nuclear Medicine Market Outlook, By Beta emitters (2016-2026) (US $MN)     
32 North America Nuclear Medicine Market Outlook, By Alpha emitters (2016-2026) (US $MN)     
33 North America Nuclear Medicine Market Outlook, By Diagnostic (2016-2026) (US $MN)     
34 North America Nuclear Medicine Market Outlook, By PET (2016-2026) (US $MN)      
35 North America Nuclear Medicine Market Outlook, By SPECT (2016-2026) (US $MN)      
36 North America Nuclear Medicine Market Outlook, By Application (2016-2026) (US $MN)     
37 North America Nuclear Medicine Market Outlook, By Therapeutic (2016-2026) (US $MN)     
38 North America Nuclear Medicine Market Outlook, By Endocrine Tumors (2016-2026) (US $MN)    
39 North America Nuclear Medicine Market Outlook, By Lymphoma (2016-2026) (US $MN)     
40 North America Nuclear Medicine Market Outlook, By Bone Metastasis (2016-2026) (US $MN)     
41 North America Nuclear Medicine Market Outlook, By Thyroid (2016-2026) (US $MN)     
42 North America Nuclear Medicine Market Outlook, By Other Therapeutic Applications (2016-2026) (US $MN)   
43 North America Nuclear Medicine Market Outlook, By Diagnostic (2016-2026) (US $MN)     
44 North America Nuclear Medicine Market Outlook, By Thyroid (2016-2026) (US $MN)     
45 North America Nuclear Medicine Market Outlook, By Neurology (2016-2026) (US $MN)     
46 North America Nuclear Medicine Market Outlook, By Lymphoma (2016-2026) (US $MN)     
47 North America Nuclear Medicine Market Outlook, By Cardiology (2016-2026) (US $MN)     
48 North America Nuclear Medicine Market Outlook, By Oncology (2016-2026) (US $MN)     
49 North America Nuclear Medicine Market Outlook, By Other Diagnostics (2016-2026) (US $MN)    
50 North America Nuclear Medicine Market Outlook, By End User (2016-2026) (US $MN)     
51 North America Nuclear Medicine Market Outlook, By Research institutes (2016-2026) (US $MN)    
52 North America Nuclear Medicine Market Outlook, By Hospitals and diagnostic centers (2016-2026) (US $MN)   
53 Europe Nuclear Medicine Market Outlook, By Country (2016-2026) (US $MN)      
54 Europe Nuclear Medicine Market Outlook, By Product (2016-2026) (US $MN)      
55 Europe Nuclear Medicine Market Outlook, By Therapeutic (2016-2026) (US $MN)      
56 Europe Nuclear Medicine Market Outlook, By Brachytherapy (2016-2026) (US $MN)     
57 Europe Nuclear Medicine Market Outlook, By Beta emitters (2016-2026) (US $MN)       
58 Europe Nuclear Medicine Market Outlook, By Alpha emitters (2016-2026) (US $MN)     
59 Europe Nuclear Medicine Market Outlook, By Diagnostic (2016-2026) (US $MN)      
60 Europe Nuclear Medicine Market Outlook, By PET (2016-2026) (US $MN)        
61 Europe Nuclear Medicine Market Outlook, By SPECT (2016-2026) (US $MN)      
62 Europe Nuclear Medicine Market Outlook, By Application (2016-2026) (US $MN)      
63 Europe Nuclear Medicine Market Outlook, By Therapeutic (2016-2026) (US $MN)      
64 Europe Nuclear Medicine Market Outlook, By Endocrine Tumors (2016-2026) (US $MN)     
65 Europe Nuclear Medicine Market Outlook, By Lymphoma (2016-2026) (US $MN)      
66 Europe Nuclear Medicine Market Outlook, By Bone Metastasis (2016-2026) (US $MN)      
67 Europe Nuclear Medicine Market Outlook, By Thyroid (2016-2026) (US $MN)      
68 Europe Nuclear Medicine Market Outlook, By Other Therapeutic Applications (2016-2026) (US $MN)    
69 Europe Nuclear Medicine Market Outlook, By Diagnostic (2016-2026) (US $MN)      
70 Europe Nuclear Medicine Market Outlook, By Thyroid (2016-2026) (US $MN)      
71 Europe Nuclear Medicine Market Outlook, By Neurology (2016-2026) (US $MN)      
72 Europe Nuclear Medicine Market Outlook, By Lymphoma (2016-2026) (US $MN)      
73 Europe Nuclear Medicine Market Outlook, By Cardiology (2016-2026) (US $MN)      
74 Europe Nuclear Medicine Market Outlook, By Oncology (2016-2026) (US $MN)      
75 Europe Nuclear Medicine Market Outlook, By Other Diagnostics (2016-2026) (US $MN)     
76 Europe Nuclear Medicine Market Outlook, By End User (2016-2026) (US $MN)      
77 Europe Nuclear Medicine Market Outlook, By Research institutes (2016-2026) (US $MN)     
78 Europe Nuclear Medicine Market Outlook, By Hospitals and diagnostic centers (2016-2026) (US $MN)    
79 Asia Pacific Nuclear Medicine Market Outlook, By Country (2016-2026) (US $MN)      
80 Asia Pacific Nuclear Medicine Market Outlook, By Product (2016-2026) (US $MN)      
81 Asia Pacific Nuclear Medicine Market Outlook, By Therapeutic (2016-2026) (US $MN)     
82 Asia Pacific Nuclear Medicine Market Outlook, By Brachytherapy (2016-2026) (US $MN)     
83 Asia Pacific Nuclear Medicine Market Outlook, By Beta emitters (2016-2026) (US $MN)     
84 Asia Pacific Nuclear Medicine Market Outlook, By Alpha emitters (2016-2026) (US $MN)     
85 Asia Pacific Nuclear Medicine Market Outlook, By Diagnostic (2016-2026) (US $MN)     
86 Asia Pacific Nuclear Medicine Market Outlook, By PET (2016-2026) (US $MN)      
87 Asia Pacific Nuclear Medicine Market Outlook, By SPECT (2016-2026) (US $MN)      
88 Asia Pacific Nuclear Medicine Market Outlook, By Application (2016-2026) (US $MN)     
89 Asia Pacific Nuclear Medicine Market Outlook, By Therapeutic (2016-2026) (US $MN)      
90 Asia Pacific Nuclear Medicine Market Outlook, By Endocrine Tumors (2016-2026) (US $MN)     
91 Asia Pacific Nuclear Medicine Market Outlook, By Lymphoma (2016-2026) (US $MN)     
92 Asia Pacific Nuclear Medicine Market Outlook, By Bone Metastasis (2016-2026) (US $MN)     
93 Asia Pacific Nuclear Medicine Market Outlook, By Thyroid (2016-2026) (US $MN)      
94 Asia Pacific Nuclear Medicine Market Outlook, By Other Therapeutic Applications (2016-2026) (US $MN)   
95 Asia Pacific Nuclear Medicine Market Outlook, By Diagnostic (2016-2026) (US $MN)     
96 Asia Pacific Nuclear Medicine Market Outlook, By Thyroid (2016-2026) (US $MN)      
97 Asia Pacific Nuclear Medicine Market Outlook, By Neurology (2016-2026) (US $MN)     
98 Asia Pacific Nuclear Medicine Market Outlook, By Lymphoma (2016-2026) (US $MN)     
99 Asia Pacific Nuclear Medicine Market Outlook, By Cardiology (2016-2026) (US $MN)     
100 Asia Pacific Nuclear Medicine Market Outlook, By Oncology (2016-2026) (US $MN)      
101 Asia Pacific Nuclear Medicine Market Outlook, By Other Diagnostics (2016-2026) (US $MN)     
102 Asia Pacific Nuclear Medicine Market Outlook, By End User (2016-2026) (US $MN)      
103 Asia Pacific Nuclear Medicine Market Outlook, By Research institutes (2016-2026) (US $MN)     
104 Asia Pacific Nuclear Medicine Market Outlook, By Hospitals and diagnostic centers (2016-2026) (US $MN)   
105 South America Nuclear Medicine Market Outlook, By Country (2016-2026) (US $MN)     
106 South America Nuclear Medicine Market Outlook, By Product (2016-2026) (US $MN)     
107 South America Nuclear Medicine Market Outlook, By Therapeutic (2016-2026) (US $MN)     
108 South America Nuclear Medicine Market Outlook, By Brachytherapy (2016-2026) (US $MN)     
109 South America Nuclear Medicine Market Outlook, By Beta emitters (2016-2026) (US $MN)     
110 South America Nuclear Medicine Market Outlook, By Alpha emitters (2016-2026) (US $MN)     
111 South America Nuclear Medicine Market Outlook, By Diagnostic (2016-2026) (US $MN)     
112 South America Nuclear Medicine Market Outlook, By PET (2016-2026) (US $MN)      
113 South America Nuclear Medicine Market Outlook, By SPECT (2016-2026) (US $MN)      
114 South America Nuclear Medicine Market Outlook, By Application (2016-2026) (US $MN)     
115 South America Nuclear Medicine Market Outlook, By Therapeutic (2016-2026) (US $MN)     
116 South America Nuclear Medicine Market Outlook, By Endocrine Tumors (2016-2026) (US $MN)    
117 South America Nuclear Medicine Market Outlook, By Lymphoma (2016-2026) (US $MN)     
118 South America Nuclear Medicine Market Outlook, By Bone Metastasis (2016-2026) (US $MN)     
119 South America Nuclear Medicine Market Outlook, By Thyroid (2016-2026) (US $MN)     
120 South America Nuclear Medicine Market Outlook, By Other Therapeutic Applications (2016-2026) (US $MN)   
121 South America Nuclear Medicine Market Outlook, By Diagnostic (2016-2026) (US $MN)     
122 South America Nuclear Medicine Market Outlook, By Thyroid (2016-2026) (US $MN)     
123 South America Nuclear Medicine Market Outlook, By Neurology (2016-2026) (US $MN)     
124 South America Nuclear Medicine Market Outlook, By Lymphoma (2016-2026) (US $MN)     
125 South America Nuclear Medicine Market Outlook, By Cardiology (2016-2026) (US $MN)     
126 South America Nuclear Medicine Market Outlook, By Oncology (2016-2026) (US $MN)     
127 South America Nuclear Medicine Market Outlook, By Other Diagnostics (2016-2026) (US $MN)    
128 South America Nuclear Medicine Market Outlook, By End User (2016-2026) (US $MN)     
129 South America Nuclear Medicine Market Outlook, By Research institutes (2016-2026) (US $MN)    
130 South America Nuclear Medicine Market Outlook, By Hospitals and diagnostic centers (2016-2026) (US $MN)   
131 Middle East & Africa Nuclear Medicine Market Outlook, By Country (2016-2026) (US $MN)     
132 Middle East & Africa Nuclear Medicine Market Outlook, By Product (2016-2026) (US $MN)     
133 Middle East & Africa Nuclear Medicine Market Outlook, By Therapeutic (2016-2026) (US $MN)    
134 Middle East & Africa Nuclear Medicine Market Outlook, By Brachytherapy (2016-2026) (US $MN)    
135 Middle East & Africa Nuclear Medicine Market Outlook, By Beta emitters (2016-2026) (US $MN)    
136 Middle East & Africa Nuclear Medicine Market Outlook, By Alpha emitters (2016-2026) (US $MN)    
137 Middle East & Africa Nuclear Medicine Market Outlook, By Diagnostic (2016-2026) (US $MN)     
138 Middle East & Africa Nuclear Medicine Market Outlook, By PET (2016-2026) (US $MN)     
139 Middle East & Africa Nuclear Medicine Market Outlook, By SPECT (2016-2026) (US $MN)     
140 Middle East & Africa Nuclear Medicine Market Outlook, By Application (2016-2026) (US $MN)     
141 Middle East & Africa Nuclear Medicine Market Outlook, By Therapeutic (2016-2026) (US $MN)    
142 Middle East & Africa Nuclear Medicine Market Outlook, By Endocrine Tumors (2016-2026) (US $MN)    
143 Middle East & Africa Nuclear Medicine Market Outlook, By Lymphoma (2016-2026) (US $MN)     
144 Middle East & Africa Nuclear Medicine Market Outlook, By Bone Metastasis (2016-2026) (US $MN)    
145 Middle East & Africa Nuclear Medicine Market Outlook, By Thyroid (2016-2026) (US $MN)     
146 Middle East & Africa Nuclear Medicine Market Outlook, By Other Therapeutic Applications (2016-2026) (US $MN)   
147 Middle East & Africa Nuclear Medicine Market Outlook, By Diagnostic (2016-2026) (US $MN)     
148 Middle East & Africa Nuclear Medicine Market Outlook, By Thyroid (2016-2026) (US $MN)     
149 Middle East & Africa Nuclear Medicine Market Outlook, By Neurology (2016-2026) (US $MN)     
150 Middle East & Africa Nuclear Medicine Market Outlook, By Lymphoma (2016-2026) (US $MN)     
151 Middle East & Africa Nuclear Medicine Market Outlook, By Cardiology (2016-2026) (US $MN)     
152 Middle East & Africa Nuclear Medicine Market Outlook, By Oncology (2016-2026) (US $MN)     
153 Middle East & Africa Nuclear Medicine Market Outlook, By Other Diagnostics (2016-2026) (US $MN)    
154 Middle East & Africa Nuclear Medicine Market Outlook, By End User (2016-2026) (US $MN)     
155 Middle East & Africa Nuclear Medicine Market Outlook, By Research institutes (2016-2026) (US $MN)    
156 Middle East & Africa Nuclear Medicine Market Outlook, By Hospitals and diagnostic centers (2016-2026) (US $MN)   

1. What do I do if I have a query on this report?
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: [email protected] or phone: +1-301-202-5929
2. Is the sample available for this report? Can I request the sample with my specific requirements?
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
3. Format of the report?
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: [email protected] or phone: +1-301-202-5929
4. Services prior to purchase and after purchase?
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at [email protected] or call us on +1-301-202-5929.
5. License Type and Delivery?
We have 3 different licensing options available in electronic format.
  • Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
  • 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
  • Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment
6. Purchase procedure and Invoicing?
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards
7. Post sale support?
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.

We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at [email protected] or call us on +1-301-202-5929.

Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.

Select License Type

Single User License (PDF)

 

2 - 5 User License (PDF)

 

Site License (PDF)

 

Corporate License (PDF)

 

Have a Question?


Know our Methodology

WHY CHOOSE US ?

Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Adding more values to your product of interest.

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Serving the most reputed brands across the world.

Testimonials